Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…
Compounds having thromboxane antagonist activity are of use in the treatment of dysmenorrhea, endometriosis and fibroids. Thromboxane antagonists of particular value are compounds of formula (I> wherein is e.g. a bicyclo-heptane, -h…